What Blue Horizon Charitable Foundation does

Blue Horizon Charitable Foundation is a 501(c)(3) nonprofit organization founded in 2010 and headquartered at 330 E. 38th St. in New York. Its mission is to finance and advance stem cell therapies and cellular regenerative medicine research while delivering charitable medical care to underserved populations. The foundation is closely associated with founder and Chief Medical Officer Dr. Brian Mehling, M.D., an orthopedic trauma surgeon, and with CEO Doreen Santora, RN, MHA, who oversees the affiliated entity Blue Horizon International (BHI) and its subsidiary BHI Therapeutic Sciences (BHITS). Adjacent entities include Mehling Orthopedics, a trauma practice performing complex orthopedic and sports medicine surgeries, and Industrial Motion Pictures, which produces the foundation's awareness documentaries.

The foundation's underlying technology centers on mesenchymal stem cells derived from human umbilical cord tissue and blood, stromal vascular fraction (SVF) cells, Wharton's Jelly mesenchymal stem cells, and human umbilical cord blood mononuclear cells (hUCMNCs). These modalities are deployed across orthopedic (osteoarthritis, joint injury), neurological (stroke, spinal cord injury, multiple sclerosis), and inflammatory indications. BHITS is currently engaged in an FDA Investigational New Drug trial for stroke using hUCMNCs, with cited clinical outcomes including 97 stroke subjects and 30 spinal cord injury subjects showing measurable improvement in mobility, muscle strength, pain sensation, and neurological function. The foundation additionally pursued FDA endorsement in 2020 for a COVID-19 pneumonia clinical trial using umbilical cord-derived mesenchymal stem cells.

The foundation operates on a charitable donations revenue model and does not maintain a commercial pricing structure. Tax-deductible gifts support medical centers and clinics, the provision of medicines, advanced medical treatments, stem cell research and development, orphan support, and documentary production. Service delivery occurs through the affiliated BHI network, which runs stem cell therapy clinics in Jamaica and Slovakia (Malacky Hospital, licensed by the Slovak Ministry of Health). Charitable programs and awareness activities span the United States, China, Thailand, Uganda, Brazil, Slovakia, and Jamaica. Distribution is supported by documentary filmmaking (including Tiny Tears, debuted at the Cannes Film Festival, and Stem Cells: The Revolution Is Here, premiered at the Chelsea Film Festival in 2021), participation in medical conferences (AAOS, World Congress of Society for Brain Mapping and Therapeutics) and the World Economic Forum at Davos.

Name

Blue Horizon Charitable Foundation

Legal name

Blue Horizon Charitable Foundation

Website

https://bluehorizonfoundation.org

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Blue Horizon Charitable Foundation is a 501(c)(3) nonprofit founded in 2010 that finances stem cell and regenerative medicine research while delivering charitable medical care to underserved adults and children globally.

Ownership category

akta.pro rank

Product category

Charitable Medical Research

NAICS

Grantmaking Foundations (813211), Grantmaking and Giving Services (81321), Civic and Social Organizations (813410)

SIC

Services-Health Services (8000), Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Hospitals, Clinics & Charitable Healthcare Providers (BPAGACAB), Private Foundations (BPAGAKAA)

Keywords

• Stem cell therapy
• Cellular regenerative medicine
• Charitable medical research
• Orthopedic trauma care
• Clinical stem cell trials

Headquarters

HQ city

New City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Charitable Donations: The foundation operates as a 501(c)(3) charitable organization, raising capital through donations to support medical centers, clinics, medicines, advanced medical treatments, and stem cell research and development

Distribution channels2 records

Marketing channels4 records

Core offering

Blue Horizon Charitable Foundation is a 501(c)(3) nonprofit organization that finances and advances stem cell therapies and cellular regenerative medicine research. It funds FDA-endorsed clinical trials, supports affiliated clinics in Slovakia and Jamaica delivering mesenchymal stem cell and umbilical cord blood therapies for orthopedic, neurological, and chronic conditions, and provides charitable medical care to underserved adults and children globally.

Product overview

Blue Horizon Charitable Foundation operates as a 501(c)(3) charitable organization focused on advancing stem cell therapies and cellular regenerative medicine. The foundation supports its affiliated entities including BHI Therapeutic Sciences, which provides stem cell treatments at facilities in Slovakia and Jamaica, and Mehling Orthopedics, which offers orthopedic trauma care incorporating stem cell therapies. The organization conducts FDA-endorsed clinical trials, produces documentary films to raise awareness about healthcare disparities, and provides charitable medical care to underserved populations globally.

Differentiator

Problem solved

Functional benefit

Brands

• Blue Horizon Stem Cells: Stem cell therapy research and treatment protocol brand associated with the foundation
• BHI Therapeutic Sciences
• Mehling Orthopedics

Products and services

• Stem Cell Therapy Programs Stem cell research protocols and clinical treatments utilizing mesenchymal stem cells from human umbilical cord, stromal vascular fraction cells, Wharton's Jelly, and cord blood for therapeutic applications in orthopedic, neurological, and inflammatory conditions. Intended for patients seeking innovative therapies for chronic conditions including arthritis, spinal cord injury, stroke, multiple sclerosis, and hip injuries.
• Documentary Films Documentary film productions including 'Tiny Tears' (about children affected by HIV/AIDS in Thailand, Uganda, Brazil, and the United States), 'Stem Cells: The Revolution Is Here', and 'Stem Cells: The Next Frontier' to raise awareness of healthcare inequalities and stem cell therapies. Targeted at global audiences, supporters, and policy makers.

Quantifiable outcome

• 97 stroke research subjects showed significant improvement in mobility, muscle strength, and neurological function
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered minor and core.

• Industrial Motion PicturesminorStrategic or Co-development Partner · 1 January 2021Dr. Brian Mehling serves as president and CEO of Industrial Motion Pictures (IMP), producer of documentary films including Tiny Tears (debuted at Cannes Film Festival) and Stem Cells: The Revolution Is Here.
• BHI Therapeutic SciencescoreStrategic or Co-development PartnerBHI Therapeutic Sciences (BHITS) is a subsidiary focused on pioneering ethical, effective, safe and affordable stem cell treatment therapies utilizing cord blood stem cells. Currently engaged in FDA Investigational New Drug trials for stroke using human umbilical cord blood stem cells. Operates clinics in Slovakia and Jamaica.
• Blue Horizon InternationalcoreStrategic or Co-development PartnerBlue Horizon International (BHI) is a healthcare consulting company combining treatment, research, and philanthropic efforts. Provides quality care and services for medical treatments along with resources for medically underserved adults and children globally.
• Mehling OrthopedicscoreStrategic or Co-development PartnerOrthopedic trauma practice dedicated to creating individualized treatment plans for traumatic injuries and disabilities. Performs complex orthopedic fracture surgeries including high velocity fractures, open fractures, complex pelvic ring injuries, and sports medicine surgeries.
• Malacky HospitalcoreStrategic or Co-development PartnerPrivate hospital in western Slovakia, short car ride from Vienna. Fully licensed by Ministry of Health of Slovak Republic. The only medical institute performing treatment of hip and knee osteoarthrosis with stem cells using BHI technology. Offers high-quality, comprehensive, customized healthcare solutions.
• Johns Hopkins University School of MedicineminorImplementation/ SI/ Consulting PartnerJoint CME sponsor for the World Congress of Society for Brain Mapping and Therapeutics. Co-sponsored program with Saint Louis University School of Medicine.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Alliance for Regenerative Medicine: International advocacy organization representing the regenerative medicine sector — comparable mission of advancing the field through education, policy engagement, and stakeholder mobilization.
• Mesoblast Limited: Publicly-traded cellular medicines company with approved and late-stage mesenchymal stem cell therapies — comparable in modality (MSC) and indication breadth but operating as a commercial pharmaceutical developer.
• Cystic Fibrosis Foundation: Large disease-specific research and care foundation with a mature model of funding academic research, running clinical trials, and supporting patient access — a scaled analog of Blue Horizon's disease-focused grantmaking approach.
• Michael J. Fox Foundation for Parkinson's Research: Large nonprofit funding Parkinson's research including cell-based therapies — a model for how a celebrity/patient-driven foundation can scale medical research grantmaking to global clinical impact.
• Damon Runyon Cancer Research Foundation: Established nonprofit funding high-impact biomedical research through grants to early-career scientists — comparable as a private foundation model for medical research grantmaking, though focused on oncology.

Emerging players

• Athersys, Inc. Clinical-stage biotechnology company developing MultiStem cell therapy for stroke and other conditions — directly comparable therapeutic focus on cord-blood-derived cell therapy for stroke, but as a commercial enterprise rather than a foundation.

Direct peers

• New York Stem Cell Foundation: Nonprofit research organization also based in New York that conducts and funds stem cell research with clinical translation programs — directly comparable mission, geography, and operational model.
• California Institute for Regenerative Medicine (CIRM): California's state-funded stem cell research agency is the most direct peer — a grantmaking organization funding stem cell and regenerative medicine research with regulatory engagement and clinical trial support, materially larger and government-backed.
• Regenerative Medicine Foundation: Nonprofit advocacy and education organization focused on advancing regenerative medicine; comparable mission of awareness-raising and stakeholder mobilization in the stem cell sector.

Others

• International Society for Stem Cell Research (ISSCR): Global scientific society setting standards and guidelines for stem cell research — comparable as a sector-standard-setting body that the foundation's protocols must align with for credibility.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BHCF_
• Facebookfacebook.com/Blue-Horizon-Foundation-156468964469874
• Instagraminstagram.com/bhcfny
• Pinterestpinterest.com/katarina0752/blue-horizon-charitable-foundation
• LinkedInlinkedin.com/company/bhcfny

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blue Horizon Charitable Foundation